1Life Healthcare, Inc.
If you purchased 1Life Healthcare, Inc. securities and would like to join the action, please click "Join This Action" below.
1LIFE HEALTHCARE MERGER INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE MERGER OF 1LIFE HEALTHCARE, INC. IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM – ONEM
June 7, 2021.
New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of 1Life Healthcare, Inc. (NASDAQ: ONEM) and Iora Health is fair to 1Life Healthcare shareholders. Iora Health shareholders are expected to receive 1Life Healthcare common stock in connection with the merger. Upon completion of the transaction, 1Life Healthcare shareholders are expected to own approximately 73% of the combined company.
The investigation concerns whether 1Life Healthcare and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for 1Life Healthcare shareholders; and (2) disclose all material information necessary for 1Life Healthcare shareholders to adequately assess and value the merger consideration. On behalf of 1Life Healthcare shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.